Showing 1-10 of 118 results for "".
- Jonathan Wolfe, MD, FAADhttps://practicaldermatology.com/profiles/jonathan-wolfe-md-faad/j36oz5/
- Jonathan Wolfe, MDhttps://practicaldermatology.com/profiles/jonathan-wolfe-md/La5vWV/
Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Histopathologic Assessment of Atypical Pigmented Lesions: Financial and Diagnostic Considerations
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histopathologic-assessment-of-atypical-pigmented-lesions-financial-and-diagnostic-considerations/21335/Taking prospective deeper sections may prove more cost-efficient in the long-term.Melanoma Rates Rising in Young Adults: Are UV Lamps to Blame?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-rates-rising-in-young-adults-are-uv-lamps-to-blame/21644/New data suggest that the rate of melanoma among individuals age 18 to 39 is on the increase, with poor UV protection strategies implicated.Regression in Primary Melanomas: Histologic Factors and Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/regression-in-primary-melanomas-histologic-factors-and-prognosis/21367/Regression was once thought to be a negative prognostic factor in primary melanomas, but new findings suggest otherwise.Assessing the Need for Re-Excision in Mild to Moderate Dysplastic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-the-need-for-re-excision-in-mild-to-moderate-dysplastic-nevi/21247/Re-excision may not be clinically warranted in a majority of cases.Invasive Melanoma: Incidence, Mortality Continue to Climb
https://practicaldermatology.com/topics/practice-management/invasive-melanoma-incidence-mortality-continue-to-climb/20780/The burden of disease is growing, despite best efforts to combat melanoma.Can Vitamin B3 Reduce Recurrence of NMSC?
https://practicaldermatology.com/topics/practice-management/can-vitamin-b3-reduce-recurrence-of-nmsc/21165/A common OTC vitamin supplement shows early promise in preventing secondary NMSCs. Is it time to recommend it?Update: Oral Therapies for the Treatment of BCC
https://practicaldermatology.com/topics/practice-management/update-oral-therapies-for-the-treatment-of-bcc/21132/With the recent FDA approval of a new oral agent, the therapeutic outlook for BCC is both more diverse and promising.
- Prev
- Next